WAIC 2026: When Medical AI Moves Beyond the Model

Your tokens are cheap. Your model is open-source. So what do you actually own?

That question shaped my review of WAIC 2026, held in Shanghai.

More than 1,100 companies presented over 3,000 exhibits. But the real divide was not between larger and smaller models. It was between technologies that attract attention and those approaching defensible, revenue-generating deployment.

Over three days, I examined the most relevant medical AI cases through the Mans International SMAF lens: the Scenario Maturity Assessment Framework, which looks beyond model parameters to assess proprietary data, workflow integration, buyer readiness, trust and commercial scalability.

Three trends stood out and they were not equally mature.

Trend 1: The moat moved from the model to the data

Leading companies are no longer applying general models directly to medical questions; they are building “medically enhanced large models” grounded in exclusive data.

A prime example is Baichuan Intelligence’s “Futang·Baichuan’s pediatric model. It was developed with Beijing Children’s Hospital using the clinical expertise of more than 300 paediatric specialists and decades of high-quality, de-identified medical records.

The results are striking: in a head-to-head against 12 attending and resident physicians on 60 real outpatient cases, it hit 91.7% diagnostic accuracy, nearly 15 points above the human average, with 92% medication-safety compliance. It now lives in daily multidisciplinary clinics and is rolled out to 150+ county hospitals in Hebei.

Trend 1: The moat moved from the model to the data Mans International — Trend 1: The moat moved from the model to the data

China also presents a compelling initial scenario. Leading paediatric expertise is concentrated in major hospitals, while primary-care and county-level institutions often lack experienced specialists. AI could help distribute medical expertise more widely, not by replacing doctors, but by allowing expert knowledge to travel across institutions and regions.

SMAF read: A static dataset can eventually be copied. A clinical system that improves through validated feedback from each deployment becomes increasingly trusted and harder to replace.

Trend 2: Embodied AI is dazzling — and still maturity-gated

United Imaging Intelligence’s equipment-data-algorithm stack is a real hardware moat that pure software players can’t easily copy. And the humanoid demos were the crowd favorite: Galaxy General’s “AstraBrain” architecture driving a robot through folding laundry and making breakfast; Fourier Intelligence’s GR-3 Care-bot executing a full intent-to-action loop from a spoken “I’m thirsty”; Optics Valley Dongzhi’s “Photon” robots handling patrol, companionship, and health monitoring in elder-care settings.

Impressive. Not yet mature. Getting a robot from a booth into a home or hospital means clearing three hurdles that don’t show up in a product demo:

Safety — the care recipients are disabled or elderly; failure tolerance is close to zero.
Privacy — continuous in-home data collection needs real consent architecture, not a terms-of-service checkbox.
Humanity — the job is care, not just task completion. A robot that folds shirts perfectly but feels clinical hasn’t solved the actual problem.

SMAF read: high potential, low current maturity. This is the category where the technology outpaces the scenario — worth watching, not yet worth pricing as though it’s solved.

Trend 3: Narrow problem, Real payers — OPC models are proving maturity can be earned fast

The most interesting founder story at WAIC wasn’t a lab spinout. TideFlow AI, an “AI personalized sleep decision system” was built solo by Wu Songyun, no medical background, just her own struggle with insomnia.

TideFlow’s core insight is that insomnia often stems not from a poor environment, but from a hyperaroused brain. The system uses AI to perceive the user’s state in real-time, dynamically matching intervention plans to help the brain naturally transition into sleep. After 12 iterations, this highly personalized, lightweight business architecture stepped onto the global stage, acquiring real paying users overseas.

SMAF read: this is what fast-tracked maturity looks like — a narrow, well-defined pain point, a founder close enough to it to iterate quickly, and payers who validate the solution before the funding round does.

The Mans International Takeaway

In this profound transformation, the core of industry competition is undergoing a structural reshaping from “Model IQ” to “Scenario EQ.” This is not short-term technological hype; it is a fundamental shift in the logic of value creation, capture, and defense.

Navigating this structural change requires far more than financial reports and model parameters. It demands a precise grasp of regulatory boundaries and a professional analytical framework capable of systematically assessing scenario maturity and identifying strategic gaps. This is precisely the design intent behind the Mans International SMAF.

Ultimately, every medical AI participant must confront a fundamental question: Is your AI strategy designed to win brief applause at the exhibition booth, or to truly crack the real industry dilemma of waiting three hours to see a doctor for five minutes?

If you’re trying to figure out where a specific medical AI bet actually sits on that maturity curve — or how to position a product for international scaling — that’s the exact gap SMAF was built to close. Happy to compare notes.

Mans International applies the Scenario Maturity Assessment Framework to help technology founders and investors distinguish technical readiness from commercial, workflow and ecosystem readiness—particularly across China and international markets.

July 15, 2026July 15, 2026

从模型IQ到场景EQ：DeepSeek为何死磕“情感智能”？

根据胡润研究院发布的《2026全球独角兽榜》，DeepSeek以3400亿元人民币估值跻身全球前 15 名。

在 DeepSeek 最新的招聘名单中有一个看似小众的岗位，正在成为全行业的风向标 ——情感智能数据产品经理。

这个岗位的核心任务，是搭建情商与意图理解的评测体系，把真实世界里模糊不清的情绪、潜台词、言外之意，拆解成大模型可量化、可训练、可迭代的标准步骤。

建议先观看上方视频洞察，再向下阅读完整战略拆解。

SMAF 诊断：情感 AI 的真正壁垒在哪里？

SMAF（Scenario Maturity Assessment Framework，场景成熟度评估框架）是我用来对 AI 产品商业生态准备度进行“压力测试”的核心工具。站在 SMAF 的视角审视， DeepSeek 的最新招聘，行业信号非常清晰：

“大模型的下半场，不再是‘模型 IQ’的技术内卷，而是‘场景 EQ’的商业化落地之战。”

SMAF 诊断：情感 AI 的真正壁垒在哪里？Mans International

在真实的商业交互中，算法面临的挑战远比跑分榜单复杂得多：

什么时候，用户是真的生气？
什么时候，用户只是陷入沉默？
什么时候，用户嘴上说“没事”，但实际上已经彻底失去信任？
什么时候，客户说“再看看”，背后其实是预算、风险、组织阻力或文化语境的深层错位？

这些精微的判断，无法单靠模型规模的扩大自然生长出来。它们需要被系统观察、精细化标注、标准化评测、针对性训练，并最终持续沉淀进产品的反馈闭环中。

换句话说，情感智能的核心壁垒，本质上是“场景数据成熟度（Data Maturity）”的问题。

在 SMAF 框架中，数据成熟度不是“拥有更多数据”，而是企业能否把真实场景中模糊、碎片化、非标准化的情绪信号，转化为可评测、可训练、可迭代、可商业化的完整数据闭环（Closed-loop flywheel）。

这也正是“情感智能数据产品经理”值得所有创始人和投资人深度关注的原因：

它不是一个偏向人文的“软岗位”，而是一个非常硬核的商业信号——AI 正在从“回答问题”的工具阶段，进入“理解人性”的复杂场景阶段。

Woebot 给情感 AI 行业留下的提醒

Woebot Health 曾是全球数字心理健康赛道的标杆级先行者。凭借将认知行为疗法（CBT）工具化融入对话交互的开创性设计，它一度在 AI 心理支持领域建立起极强的行业辨识度。然而，根据官方公告，其面向 C 端用户的 Woebot App 已于2025 年 6 月 30 日正式停止服务。

The Woebot Reality Check: 临床背书 ≠ 商业飞轮

这是一场值得全行业深度复盘的现实校验。脱胎于斯坦福学术体系、手握 FDA 突破性设备认定，Woebot 拥有绝大多数同行难以企及的临床背书。但它始终未能搭建起可持续运转的商业飞轮（Closed-loop flywheel）。

站在SMAF（场景成熟度评估框架）的透镜下审视，这并非科学或算法的失败，而是典型的场景成熟度缺口（Scenario Maturity Gap）——叙事定位、工作流融合与商业模式三者成熟度的严重错位。

The Woebot Reality Check: 临床背书 ≠ 商业飞轮 Mans International — The Woebot Reality Check: 临床背书 ≠ 商业飞轮

它的停运，不能直接否定 AI 心理健康的庞大需求，也不代表 Woebot Health 彻底退出赛道。但它给整个情感 AI 行业留下了一个极其冷酷的警示：

扎实的临床研究、顺滑的产品体验、真实的用户需求，甚至官方的监管认可，都不会自动拼接成一套可持续运转的商业飞轮。

SMAF灵魂拷问：情感AI必须跨越的六道鸿沟

一款数字心理健康或情感 AI 产品要真正跑通商业闭环，不能仅停留在技术自嗨，必须在 SMAF 框架下同时回答以下六个核心问题：

Procurement Trigger（采购触发点）：谁是真正的付费主体？是C端用户、企业员工福利部门、保险机构，还是医疗服务机构？产品解决的问题是否足够紧迫，能够进入一个明确、持续的预算科目？
Workflow Embedding（工作流嵌入）：产品能否自然进入用户已有的医疗服务、员工关怀或日常健康管理流程？还是需要用户额外下载、学习并主动打开一个长期孤立的App？
Retention & Flywheel（留存与飞轮）：用户为什么持续使用，而不是短暂尝鲜？长期交互是否能够形成可验证、可持续的数据反馈闭环，并推动产品能力和用户价值同步提升？
Role Boundary（角色与责任边界）：AI和专业人员之间如何分工？产品提供的是信息支持、情绪陪伴、行为引导，还是涉及临床判断与干预？不同角色对应的责任、风险和合规要求是否已经明确？
Risk Escalation（风险升级机制）：当模型无法判断、出现幻觉，或者识别到潜在的高风险心理状态时，产品如何升级至人工支持或专业服务？这一机制是否及时、可追踪，并符合当地监管与伦理要求？
Outcome Measurement（结果度量）：企业如何证明产品创造了真实结果？它改善的是用户健康状态、服务效率和风险管理，还是仅仅增加了使用时长、对话次数与App日活？？

SMAF灵魂拷问：情感AI必须跨越的六道鸿沟 Mans International

这六个问题并不是情感AI商业化的完整答案，而是判断场景是否具备基本成熟度的起点。

模型可以识别情绪，不代表企业已经找到了付费方；用户愿意聊天，不代表产品能够形成留存；监管认可、临床研究和高互动率，也不会自动形成可持续的商业飞轮。

技术证明产品能够工作。场景成熟度决定它能否被购买、被信任并持续运行。

如果你正在构建下一代情感 AI 产品，或者正在筹备 AI 产品的全球化与跨区域落地，不要只盯着模型参数量与跑分榜单。真正决定胜负的，是你对场景的理解深度，以及对人性的精准把握。

欢迎在评论区聊聊：你所在的行业，有哪些被忽略的 “情绪摩擦” 正在成为业务瓶颈？

如果你希望对自身业务做一次完整的场景成熟度评估，也欢迎私信联系，预约定向邀请制的场景成熟度审计服务。我们将输出完整的场景成熟度定级与跨文化落地缺口清单，帮你在投入重金之前，先看清商业生态的真实底牌。

July 15, 2026July 15, 2026

AI’s Next 99.5% Opportunity: Why the Winners Will Be Built Beyond SaaS

The 0.5% SaaS Trap: AI’s “Pixar Moment”

In the early 1980s, Pixar wasn’t a film studio. It was a struggling hardware company born inside Lucasfilm and backed by Steve Jobs. They built the Pixar Image Computer — a sleek, powerful machine designed for medical imaging and scientific visualization.

Nobody wanted it. No hospitals, no research labs, not even George Lucas. As Pixar bled cash, they had one odd advantage: a tiny in-house team making short animated clips just to demonstrate what the hardware could do. The hardware flopped, but the clips blew people’s minds.

So, Pixar made a radical creative leap: they stopped selling the silicon and started selling the story. They stopped optimizing a tool and reimagined its ultimate purpose. The result was Toy Story, and it rewrote the economics of Hollywood.

The 0.5% SaaS Trap: AI’s “Pixar Moment” Mans International — The 0.5% SaaS Trap: AI’s “Pixar Moment”

Today, AI founders are facing their own “Pixar moment.” Too many are obsessing over the underlying technology, the tool itself, while missing the grander narrative of the market: delivering undeniable, real-world outcomes.

This fixation has led to what can be called the 0.5% SaaS trap: founders are optimizing for the easiest layer of AI adoption while completely missing the massive 99.5% opportunity waiting in the real economy.

The Canary in the SaaS Coal Mine

Goldman Sachs recently published a sobering metric for the tech ecosystem: software services (SaaS) represent less than 0.5% of global GDP. The remaining 99.5% belongs to the physical world — manufacturing, energy, logistics, healthcare, construction, and robotics.

For the past year, we’ve watched software companies face a massive reality check. The ten largest holdings in a major software ETF collectively shed nearly $800 billion in market cap. This isn’t because software is dying; it’s because AI is breaking the traditional SaaS business model.

The old assumptions — that pricing should be based on user seats, that more users equal more value, or that adding a basic wrapper creates a defensive moat — are collapsing. As autonomous AI agents begin to do the actual work, value is shifting away from software access and moving directly toward trusted, physical outcomes.

The Canary in the SaaS Coal Mine Mans International — The Canary in the SaaS Coal Mine

The capital is already moving. Look at Prometheus, the AI engineering startup backed by Jeff Bezos that recently raised $12 billion at a $41 billion valuation. They aren’t building a better chatbot to write marketing emails; they are building an AI engineer to design physical jet engines and complex industrial systems.

The real battleground is the remaining 99.5% of the economy. But conquering it requires playing by an entirely different set of rules.

The 5 Laws of Industrial AI

In software, an AI hallucination wastes tokens. A confident but wrong AI answer isn’t just a product bug. In industrial settings, it can quickly turn into a trust and liability problem. Goldman Sachs highlights five capabilities that may separate industrial-AI leaders from commoditized competitors:

Physics-Based Architecture: AI must understand materials, motion, temperature and mechanical constraints — not just language.
Proprietary Operational Data: The strongest moats will come from private deployment data, including failures, edge cases and real-world operating patterns.
Edge Deployment: Critical systems cannot depend entirely on cloud connectivity. Intelligence must often run locally for speed, reliability and safety.
Certifiability: In regulated environments, technical performance is insufficient. The system must be demonstrably predictable, controllable and safe.
Workflow Integration: Customers will not rebuild their operations around a new tool. The highest-value AI becomes a seamless capability layer inside existing workflows.

The 5 Laws of Industrial AI Mans International

The Hidden Risk: Is Your Scenario Mature?

Goldman Sachs maps the technical requirements for the real economy. But for founders and investors, technical readiness is only half the battle. The greater risk is commercial readiness.

This is where the Scenario Maturity Assessment Framework (SMAF) becomes essential.

A technology can perform brilliantly and still fail to scale because the commercial environment around it is not ready. When industrial AI stalls, the problem is often not the product itself, but the scenario in which it is being applied. Three questions expose the gap:

The Buyer & Budget: Are you selling to a specific operational buyer with a P&L, or pitching “abstract efficiency” that no single department actually owns?
The Integration Friction: Can the product fit into existing operations, or must the customer redesign its workflow before receiving value?
The Value Capture: Are you selling software access to an industrial buyer who only cares about measurable operational and financial outcomes?

Is Your Scenario Mature? Mans International

Remember Pixar? Their Image Computer was technically brilliant. But the scenario was immature. They were applying a world-class capability to the struggling hardware scenario — until they pivoted to a more valuable outcome: computer-generated storytelling.

The next generation of AI winners will not necessarily have the most sophisticated models. They will be the companies that translate AI into outcomes that are trusted, workflow-integrated and commercially measurable.

When the technology works but adoption and revenue stall, do not immediately assume the product has failed. Audit the scenario.

At Mans International, we help deep-tech founders and investors identify where commercialization is breaking down—whether the answer is stronger workflow integration, a better value-capture model or a more mature market application.

July 9, 2026July 9, 2026

From Model IQ to Scenario EQ: DeepSeek’s Emotional Data Pivot and AI’s Next Moat

Here is the signal most founders and investors missed:

A Chinese AI company reportedly raised US$7.4 billion at around a US$50 billion valuation, cracking the global top 15 unicorns.

That company is DeepSeek — one of China’s most watched AI labs, known for challenging the global AI race with high-performing, cost-efficient large language models.

Yet after reportedly closing a massive funding round of over US$7.4 billion, or 50 billion RMB, its immediate next move was not simply a public computing-power expansion or another race to cut parameter costs. Instead, it launched a comprehensive hiring wave across 7 categories and 33 roles.

Among them, one role deserves particular attention from founders and investors: Emotional Intelligence Data Product Manager.

DeepSeek Emotional Intelligence Data Product Manager

The core responsibility of this role is about turning complex, ambiguous human emotions and intentions into evaluation systems, training workflows, and product feedback loops.

The Next AI Battle Is Not Only Model IQ. It Is Scenario EQ.

Through the lens of SMAF — Scenario Maturity Assessment Framework, our active framework to stress-test an AI company’s commercial ecosystem and value-capture architecture, DeepSeek’s hiring signal points to a deeper shift:

The next phase of AI commercialization will not be won only by higher model IQ. It will be won by stronger scenario EQ.

The Next AI Battle Is Not Only Model IQ. It Is Scenario EQ.

Can the AI detect when a customer is truly angry? Can it understand when a patient says “I’m fine,” but is actually anxious, confused, or losing trust? Can it recognize when a buyer says “let us think about it,” but the real blocker is budget, internal politics, risk perception, or cultural mismatch?

These are not simple sentiment-analysis problems. They are scenario-maturity problems.

Emotional Intelligence Is a Data Maturity Problem

In SMAF, data maturity does not mean owning more data. It means the ability to convert messy, fragmented, non-standard signals from real use cases into a repeatable loop:

Observe → Label → Evaluate → Train → Deploy → Learn Again

Emotional Intelligence Is a Data Maturity Problem Mans International

This is precisely why the “Emotional Intelligence Data Product Manager” is an essential marker for founders and institutional investors. This is not an abstract, soft-skill humanities role; it is a hard commercial signal. AI is graduating from the basic tool phase of answering questions to the complex scenario phase of decoding human intent.

Furthermore, as AI leaders shift from model-centric competition to usage-efficiency and token-economics discipline, scenario accuracy becomes a direct P&L issue. High Scenario EQ means fewer wasted interactions, fewer misinterpreted prompts, fewer repeated explanations, and fewer costly friction loops.

In enterprise AI, understanding the scenario correctly is not merely a product advantage but a path to more sustainable profitability.

The Mans International View: East–West Scenario Splintering

Technology may travel globally, but emotional intelligence does not move across markets in a straight line.

The same underlying model capability can face completely different maturity paths in North America, China, and other markets. I call this Scenario Splintering: when one technology enters different cultural, regulatory, workflow, and business environments — and each environment demands a different product logic.

The US Paradigm (Persona & Deep Alignment): Pioneers like Character.ai and Replika established an early blueprint for highly individualized relationship building, utilizing Conversation Designers, Psychology Researchers, and Dialogue Data Experts to curate explicit “personas” and empathetic baselines.
The China Paradigm (Rapid Vertical Embedding): Domestic players like Emoha (聆心智能) trained models directly on clinical counseling data to deploy its series across over 600 specific mental health, university, and enterprise scenarios. Following its integration with Zhipu to power CharacterGLM, the priority shifted to cross-ecosystem scale — immediately embedding empathetic capabilities into gaming NPCs, virtual companions, and digital human assets to maximize immediate commercial velocity.

The Mans International View: East–West Scenario Splintering

The Strategic Trap: Copy-pasting Western “clinical AI” to the East usually dies because users won’t pay for a “diagnostic” experience. Pushing Eastern “heavy-companion AI” to the West usually dies under privacy scrutiny. Cross-border Emotional AI requires Scenario Reconstruction (Cultural Translation), not just code translation.

The Woebot Reality Check

Look at Woebot Health. Despite its Stanford roots and FDA breakthrough designation, it has struggled to build a sustainable commercial flywheel.

Under the SMAF lens, this is a classic case of misalignment in narrative, workflow, and business model maturity. While their clinical narrative was strong, their workflow maturity struggled to seamlessly integrate into existing fragmented healthcare systems, and their business model faced friction reconciling the high costs of medical compliance with shifting B2B enterprise budgets. Having the best clinical design doesn’t matter if the commercial scenario isn’t mature enough to sustain the business.

The Woebot Reality Check Mans International

Execution is becoming easier. Scenario Intelligence is becoming more valuable.

At Mans International, this is the core of our SMAF work: helping founders, investors, and cross-border technology teams evaluate whether a promising AI product has matured enough to become a real commercial system.

If you are currently building the next generation of affective interfaces, or orchestrating a cross-border tech launch between Western innovation and Eastern scale, look beyond the leaderboard benchmarks.

Contact Mans International to schedule a private, selective Scenario Maturity Audit. Let’s assess your structural gaps and secure your commercial roadmap before your next major deployment.

July 1, 2026July 1, 2026

An ALS breakthrough: A master class in Deep-Tech Ecosystem Building, Founder Resilience, and SMAF

Mans International SMAF Sprint 2026

The I Ching (Book of Changes) states: “Heaven’s movement is ever vigorous; thus, the noble person constantly strives for self-improvement.” This underlying force of relentless self-renewal, regardless of the circumstances, has found its most extreme validation in the practice of Mr. Cai Lei.

In 2019, Mr. Cai Lei, a former vice president of JD.com and one of the pioneers behind China’s electronic invoice system, was diagnosed with amyotrophic lateral sclerosis, or ALS. He was 41. He had just welcomed a new child. His career, family, and life were all at a peak moment.

Then came the diagnosis. ALS is often described as one of the most devastating neurodegenerative diseases. The average survival window after diagnosis is often only a few years.

Seven years later, in 2026, his body function score plummeted from 48 to 4. He is completely paralyzed from the neck down, his vocal cords have severely atrophied, and he relies on a liquid diet and a 24-hour ventilator to survive. Across his entire body, only his eyes remain under his autonomous control.

Cai Lei before and after ALS Mans International — Cai Lei before and after ALS

Yet, Cai Lei’s story is far more than an inspiring narrative of resilience and empathy. Analyzed through the Scenario Maturity Assessment Framework (SMAF), it stands as a textbook masterclass in deep-tech scenario breakthroughs. It is a blueprint of how to take a globally recognized “unsolvable dead end” and reconstruct it into a high-maturity, self-sustaining ecosystem of research collaboration and commercial translation.

I. Deconstructing the Breakthrough via SMAF: A High-Maturity Super Ecosystem

At Mans International, we utilize the SMAF (Scenario Maturity Assessment Framework) to evaluate the commercial viability and translation potential of deep tech ventures. We have seen too many projects perish in the “slide deck” phase or or “lab-only self-indulgences.”

From a scenario maturity perspective, the true brilliance of Cai Lei’s “ice-breaking” initiative is not simply his unwavering belief, but his methodical execution. He took a highly fragmented, chronically inefficient rare-disease scenario — one lacking adequate resource attention — and orchestrated it into a synchronized system uniting patients, data, research, clinical trials, capital, AI, and public trust.

1. Data and Workflows: From Scattered Patients to R&D Infrastructure

One of the greatest bottlenecks in rare disease R&D is scattered patient populations, scarce biological samples, and a lack of real-world data. Often, research does not lack direction; it lacks a stable, continuous, and actionable data foundation.

The Data Engine: Cai Lei built the “Jianyu Mutual Aid Home,” the world’s largest civilian ALS research database (over 18,000 registered users), housing tens of thousands of structured real-world cases. He also launched an “ALS Research AI Brain,” training 24/7 on over 20 million interdisciplinary papers to automatically filter and evolve targets without burdening researchers.
The Workflow: This 360-degree dynamic vital-sign tracking system compresses notoriously slow clinical recruitment to astonishing speeds — achieving “hour-level” responsiveness (i.e. 700 sign-ups in 2 hours; launching clinical trials within 3 months).

Data and Workflows: From Scattered Patients to R&D Infrastructure Mans International — Data and Workflows: From Scattered Patients to R&D Infrastructure

2. The Business Closed Loop: A Mechanism for Long-Term Sustenance

Rare disease research cannot survive solely on short-term donations or one-off grants. Drug discovery features long cycles, high failure rates, and relentless capital demands, while external funding environments and public attention fluctuate. Without a stable financial engine, even the grandest mission will bleed out mid-way.

The partnership forged between Cai Lei and his wife, Duan Rui, perfectly demonstrates the synergy of vision and operations. Many view Duan Rui’s live-streaming efforts purely as a “wife’s sacrifice.” While deeply moving and true, from a strategic perspective, it is a brilliantly designed commercial closed loop.

Cai Lei continually raises the ceiling of their mission — connecting patients, scientists, pharma, and society. Meanwhile, Duan Rui absorbs the immense operational realities: live-streaming revenue, team management, cash flow, cost control, and risk mitigation. This closed-loop of “front-end commercial revenue funding back-end R&D burn” provides a continuous lifeline for a highly uncertain, long-cycle scientific endeavour.

The Business Closed Loop: A Mechanism for Long-Term Sustenance Mans International — The Business Closed Loop: A Mechanism for Long-Term Sustenance

3. Narrative & Ecosystem: Evolving from Empathy to Industry Consensus

Before Cai Lei, ALS was trapped in a weak narrative within public and industry discourse — viewed merely as an “incurable and unprofitable” tragedy. It garnered generalized sympathy but lacked actionable pathways.

Cai Lei elevated this narrative fundamentally. He did not stop at emotional appeals for awareness; he broke down rare-disease R&D into actionable industry propositions. He allowed the scientific community, the biotech industry, and the public to clearly see their specific roles and value.

This mature narrative has penetrated industry silos, uniting over 60 global research teams and 50+ biotech companies, transforming an untouched “cold sector” into a highly coordinated battlefield with shared consensus, pooled resources, and a synchronized tempo.

Narrative & Ecosystem: Evolving from Empathy to Industry Consensus
Mans International — **Narrative & Ecosystem: Evolving from Empathy to Industry Consensus**

II. The Founder’s Mirror: Resilience for Global Founders

In his recent “Countdown” speech on Global ALS Day, June 21, 2026, Cai Lei said he had already defeated an enemy more terrifying than ALS: despair.

For founders today — navigating agonizing market cycles and high-stakes survival tests — Cai Lei’s mental fortitude serves as a profound mirror:

Reject the Victim Mentality. Complaining about the macro environment or the “capital winter” yields zero value. Completely paralyzed and unable to speak, Cai Lei never wallowed in the unfairness of fate. He immediately pivoted his strategy, utilizing an eye-tracking device to launch a race against time. Radical acceptance and execution to the absolute limit are the foundational ethics of a founder.
Pry Open Incremental Gaps in Dead Ends. Cai Lei noted: “You might think there is only a solid wall in front of you. But look down, there might be a path; turn sideways, there is a gap. You can even choose to climb over or dig through.” When traditional funding tightens and cross-border barriers rise, a founder’s core competency is leveraging tools — like AI and cross-disciplinary ecosystems — to pry open growth spaces ignored by the mainstream.
Anchor Your Venture in a Grand Proposition. “The best way to overcome fear is to place yourself within a much greater cause.” When your corporate vision is tied to core societal challenges — hard tech breakthroughs, life sciences, energy transitions — the resilience you unlock will far surpass what secular fame or profit can sustain.

Pry Open Incremental Gaps in Dead Ends Mans International — **Pry Open Incremental Gaps in Dead Ends**

III. Conclusion: The Countdown is a Prelude to Victory

In Cai Lei’s room, four clocks sit ticking. The media calls it the countdown of his life. He corrects them: “This is my countdown to ALS.”

“If my eyes fail, I will connect to a Brain-Computer Interface. If my brain stops turning, I will upload my consciousness to an embodied robot. I have marched all the way to the face of this terminal illness, and I am not here to surrender.”

As heaven’s movement is ever vigorous, so must a leader ceaselessly strive along.

The Countdown is a Prelude to Victory
Mans International — **The Countdown is a Prelude to Victory**

Here is to all the founders who keep walking through the valleys of economic cycles. Here is to the researchers grinding relentlessly in their labs. Here is to all those who refuse to bow to fate.

Do not ask where the hope lies. Keep moving forward, and hope will reveal itself. As long as you do not retreat, every direction is the way forward.

Global Strategic Partnership

Leading global research institutions, multinational pharmaceutical companies, biotech innovators, and international funds are invited to partner with Mans International to access and navigate high-maturity life science and deep-tech ecosystems.

Through our SMAF — Scenario Maturity Assessment Framework — we help identify where technology, capital, clinical resources, market readiness, and ecosystem trust can be precisely aligned.

Our goal is to reduce cross-border and cross-sector friction, accelerate clinical and commercial translation, and support breakthrough technologies and strategic capital in moving from promise to real-world impact.

June 30, 2026June 30, 2026

蔡磊的最后一次创业：当旧地图失效创始人如何重构一个无解场景？

导语：

《易经・乾卦》有云：“天行健，君子以自强不息。” 这份无论处于哪种际遇，都能尽己所能的底层力量，在蔡磊的实践中得到了最极致的印证。

2019 年，41 岁的蔡磊确诊渐冻症（ALS）。彼时他身为京东副总裁、中国电子发票第一人，刚迎来新生命，正处于事业与家庭的双重巅峰。而医生给出的 2-5 年平均生存期，为他按下了冰冷的人生倒计时。

七年后的今天，他的身体功能评分从 48 分跌至 4 分，脖颈以下完全瘫痪，声带彻底萎缩，依赖流食与 24 小时呼吸机维持生命，全身上下仅剩双眼可以自主控制。

蔡磊的故事，远不止一场关于抗争与共情的励志叙事，从产业视角出发，用 SMAF（场景成熟度评估框架）拆解便会发现：这更是一场教科书级的深科技场景破局 —— 一套完整的成熟度体系，将全球医学界公认的 “无解绝境”，重构为高成熟度、自循环的科研协作与产业转化生态。

一、SMAF 框架深度拆解：蔡磊的 “破冰之战”，为何是罕见病领域的高成熟度超级生态

在 Mans International，我们使用SMAF（场景成熟度评估框架 / Scenario Maturity Assessment Framework）来评估深科技与跨国项目的落地潜力。我们见过太多死于“PPT造车”或“实验室自嗨”的项目。

从场景成熟度的角度看，蔡磊的“破冰”行动真正厉害的地方，不只是“相信”，而是把相信之后的每一步，把一个原本高度破碎、长期低效、缺乏足够资源关注的罕见病场景，逐步组织成了一个患者、数据、样本、科研、临床、资金、AI 与公众信任共同参与的协同系统。

1. 数据和工作流：从零散病友到研发基础设施

罕见病研发最大的难题之一，是患者分散、样本稀缺、真实世界数据不足。很多时候，科研并不是没有方向，而是缺少足够稳定、持续、可用的数据基础。

蔡磊牵头搭建的“渐愈互助之家”，是全球最大的民间渐冻症科研数据库（注册量突破18000人），收录了上万份结构化的真实世界病例。

在工作流端：这套360度动态生命指标跟踪系统，将原本极其低效的临床招募压缩到了令人惊叹的速度——实现以“小时”为单位的极速响应（2小时700人报名，3个月内开启临床）。
在数据端：他启动了“渐冻症科研AI大脑”，全天候训练全网超2000万篇跨学科文献。AI 没有增加研究员的负担，而是“消失”在科研工作中，自动过滤与进化靶点。

2. 商业闭环：使命必须有长期供血机制

罕见病科研很难完全依赖短期捐赠或单点资助。药物研发周期长、失败率高、资金需求持续，而外部融资环境、公益热度和社会关注度都会波动。如果没有稳定的资金来源，再宏大的使命也很容易在中途失血。

蔡磊和段睿所形成的夫妻共患难组合，恰恰体现了愿景与运营的互补。很多人看到段睿的直播，会首先想到“妻子的牺牲”。这当然是真实的，也是令人动容的。但在商业视角下，这是极其高明的商业闭环设计。

蔡磊负责不断拉高使命天花板，连接患者、科学家、药企和社会关注；段睿则承担大量现实层面的运营压力，包括直播、团队、资金、成本、节奏和风险控制。这种“前端商业造血+后端科研烧钱”的闭环，为一个长周期、高不确定性的科研项目，提供了一种持续供血机制。

商业闭环：使命必须有长期供血机制 Mans International — 商业闭环：使命必须有长期供血机制

3. 叙事：从悲情共情到产业行动共识

在蔡磊之前，渐冻症在公众与产业语境中，始终是 “无药可治、无利可图” 的悲情命题 —— 只有泛化的同情，没有明确的行动路径，属于典型的弱叙事场景。

蔡磊完成了叙事层面的本质升维：他没有停留在 “呼吁关注” 的情感表达，而是将罕见病研发拆解为可落地的产业命题，让科研界、产业界、公众都清晰看到自身的参与方式与价值。

这套成熟叙事最终穿透圈层，联动起全球 60 余个科研团队、50 余家生物科技公司，将 “无人敢碰的冷门赛道” 变成了有共识、有资源、有节奏的攻坚战场。

蔡磊在2026 年6月21日世界渐冻人日的《倒计时》演讲，更是进一步强化了全行业的攻坚共识，成为推动场景持续进化的精神内核。

二、天行健，君子以自强不息：给中国创始人的“心力”启示

蔡磊在最新的视频《倒计时》中说：“我已经终结了一个比他更可怕的对手，名为绝望。”

他把自己比作孙悟空，“纵使不敌，也绝不屈服”。对当下正穿越周期阵痛、直面生死考验的中国创始人而言，蔡磊的“心力”是一面镜子：

第一，摒弃受害者心态。

抱怨大环境、哀叹资本寒冬毫无价值。蔡磊全身瘫痪、彻底失语，从未沉湎于命运不公，而是立刻切换战略，以眼控仪开启 “生死时速”。接受现实，倾尽所能 —— 这是创始人最底层的职业素养。

第二，在绝境中撬开增量缝隙。

蔡磊说：“你觉得前方只有一堵墙，其实未必，低头看有路，侧身有缝，甚至你可以选择翻过去、挖过去。” 当传统融资收窄、出海壁垒高筑，创始人的核心能力，就是借助 AI 杠杆、跨界生态，撬开被主流忽略的增长空间。

在绝境中撬开增量缝隙 Mans International — 在绝境中撬开增量缝隙

第三，把事业锚定在更大的命题上。

“战胜恐惧最好的方法，就是把自己置于一个更大的事业当中。” 当企业愿景与硬科技突围、生命科学攻坚、能源变革等社会核心命题绑定，你获得的韧性，将远超世俗名利的支撑。

华大集团 CEO 尹烨是蔡磊科研生态的核心产业合作者：“你说要‘打光最后一颗子弹’，但这颗子弹会形成撞击，产生裂变，唤起更多的社会群体参与进来，共同解决。”

蔡磊以第一性原理与极致执行力，搭建起全球成熟度领先的 ALS 科研与数据基建。而攻克神经退行性疾病，不止关乎 50 万 ALS 患者，更关乎未来数十亿面临阿尔茨海默、帕金森威胁的全人类，这需要一支全球舰队的协同。

结语：倒计时，是胜利的序曲

蔡磊的房间里摆着四个时钟，滴答作响。

媒体说，那是他生命的倒计时。

他却说：“这是我送给渐冻症的倒计时。”

“如果眼睛看不见了，我会连上脑机接口；万一脑子转不动了，就把意识传送到具身机器人。我一路走到绝症面前，不是来向它投降的。”

天行健，君子以自强不息。

敬所有在周期谷底仍步履不停的创始人，敬所有在实验室死磕的科研人，敬所有不屈服于命运的前行者。

不必追问希望在何处 —— 向前走，希望自会显现。只要不退却，四面八方，皆是前路。

全球顶尖科研机构、跨国药企、Biotech 及国际基金：若您希望直通全球最大渐冻症科研生态与极速临床转化通道，请通过 Mans International 对接。我们以 SMAF 框架为您精准匹配患者数据、生物样本与临床招募资源，打通跨境跨界协同壁垒，加速您的管线从实验室走向临床。

June 25, 2026June 25, 2026

英矽智能与“AI 制药溢价”：一场 SMAF 压力测试

2023年，我曾在书中首次深度剖析英矽智能（Insilico Medicine）。当时，它凭借将AI发现的候选药物推进至FDA临床一期，成为 AI 驱动药物研发领域最耀眼的先锋。

到了2025年，英矽智能的叙事已超越了单纯的“研发速度”。它成为了一个行业试金石：AI 能否通过 PreciousGPT 平台和核心资产 Rentosertib（ISM001-055），将生物学洞察真正转化为在长寿和衰老相关疾病领域，具备临床意义与商业可行性的资产。

英矽智能与“AI 制药溢价”：一场 SMAF 压力测试 Mans International — 英矽智能与“AI 制药溢价”：一场 SMAF 压力测试

而到了 2026 年，故事变得更为复杂。

尽管英矽智能与礼来（Eli Lilly）达成了最高可达27.5亿美元（含1.15亿美元首付款）的里程碑式合作，但在2025年录得 3.523 亿美元净亏损及港股剧烈波动的背景下，其资本市场叙事仍承受着巨大压力。

这正是我将其选为 SMAF Sprint 2026 案例的原因。

核心启示在于：在 AI 商业化进程中，技术成熟度、数据成熟度、商业成熟度与叙事成熟度，往往无法同步达成。这种“多维错配”，正是场景成熟度评估框架（SMAF, Scenario Maturity Assessment Framework）旨在精准诊断的核心命题。

SMAF 框架下的核心错配：AI 技术迭代速度，远超资本市场信任建立速度

1、业务与叙事成熟度：“AI 发现新药”已无法支撑估值溢价

英矽智能真正的突破，不在于“使用了AI”，而在于将宽泛的技术愿景落地为具体的商业场景。

在长寿生物科技领域，“衰老”并非 FDA 认可的适应症。企业必须从抽象的“延长健康寿命”愿景，转向具有明确监管逻辑和可量化终点的特定疾病。英矽智能通过瞄准特发性肺纤维化（IPF），成功实现了这一跨越。

从 SMAF 视角来看，这至关重要。公司没有停留在“AI 能发现药物”的口号层面，而是选择了一个能让技术在真实世界的商业、监管、合作与临床证据要求下接受检验的疾病场景。

这就是其核心资产 Rentosertib 的意义所在。它将讨论从“AI 发现”提升到了一个更严峻的问题：“AI赋能的生物科技公司，能否将发现转化为经过验证的资产、战略合作以及可复制的商业价值？”

业务与叙事成熟度：“AI 发现新药”已无法支撑估值溢价 Mans International — 业务与叙事成熟度：“AI 发现新药”已无法支撑估值溢价

在 AI 浪潮早期，“AI 发现药物”是一个有力且简单的故事。但到了 2026 年，市场需要细节。投资者追问的是：具体靶点是什么？临床终点在哪？监管路径如何？合作伙伴是谁？资产能否规模化复制？

成熟的叙事从不夸大确定性，而是清晰地描绘从“技术可能性”到“商业现实”的路径。

对创始人的启示：市场初期或许会为 AI 的新颖性买单，但长期来看，市场只奖励经过验证的资产、可信的商业路径，以及能将技术与价值创造紧密相连的叙事。

2、跨境运营成熟度：研发效率≠全球商业信任

英矽智能是典型的东西方双轨运营 AI 药企：研发中心扎根中国香港、内地生物医药产业集群，深度依托国内完备的生物医药自动化供应链、低成本临床试验资源、海量生物组学数据以及高端算法工程师人才池。依托亚洲产业链优势，它的管线研发速度、成本控制能力远超欧美本土AI药企。

但研发提速，不等于全球商业化成功。跨境 AI 药企需要补齐一套完全独立于研发之外的能力：跨区域监管沟通、全球临床数据透明化披露、跨国药企内部尽调信任、跨境数据合规治理、地缘风险对冲。

这也是当前中资背景出海 AI 药企的隐性短板：国内团队擅长高效率产出研发数据，但不擅长向欧美药监、跨国药企、海外二级市场投资人解释数据逻辑、合规细节。研发跑得快，却无法获得全球利益相关方的信任，最终导致管线授权、海外上市估值受阻。

跨境运营成熟度：研发效率≠全球商业信任 Mans International — 跨境运营成熟度：研发效率≠全球商业信任

结合 SMAF 框架拆解四大跨境成熟度考核标准，也是投资人尽调核心要点：

商业模式能否适配跨国药企联合研发、全球分销的合作规则；
临床原始数据、算法溯源记录能否通过欧美第三方合规审查；
AI 研发全流程能否满足跨国药企最高等级商业尽调要求；
中英文双版本叙事能否消除文化、监管认知偏差。

所有跨境生物医药创始人都要回答一个底层问题：你的企业能否做到全球语境下的可理解、可核查、可信任，而非仅适配中国本土资本与产业逻辑。

3. AI 药企估值溢价并未消失，只是进入按需定价阶段

通过 SMAF 框架审视，“AI 制药溢价”不再是理所当然的。它已成为一种 “条件性溢价”，必须通过临床推进、可复制的资产、大药企验证、资本纪律以及全球认可的治理结构来赢取。

英矽智能当下的股价波动、业绩亏损，本质就是全球资本市场对AI生物医药赛道的一次实景压力测试。

溢价的获取程度，正比于这五个主要条件的满足程度：

管线临床数据持续达标、
多管线可复制研发成果、
获得头部跨国药企商业化背书、
严格管控现金流与资本开支、
搭建全球统一的数据合规治理体系。

AI 药企估值溢价并未消失，只是进入按需定价阶段 Mans International — AI 药企估值溢价并未消失，只是进入按需定价阶段

针对跨境生物医药创始人、一二级市场投资人、产业战略决策者，最终落地启示：突破性技术只是敲门砖，唯有“场景成熟度”才能让门保持敞开。对于东西方跨境药企而言，跨境资本通道不只是简单打通海内外融资、上市渠道，更要完成三层转化：

把亚洲研发速度转化为全球信任、
把实验室科研数据转化为合规临床证据、
把平台型技术愿景转化为全球统一认可的商业价值。

这正是我们在 SMAF Sprint 2026 中所执行的核心诊断。我们运用“场景成熟度评估框架（SMAF）”，协助创始人、投资者与战略决策者厘清一个核心命题：

如果技术本身是成立的，其周边的商业场景是否足够成熟，足以将其转化为真正的市场采用、营收增长与持久的战略价值？

June 25, 2026June 30, 2026

China’s Embodied AI Playbook: Cost Shock, Narrative Maturity, and the Workflow Test

Following our assessments of Insilico Medicine’s algorithmic drug discovery architecture in Case Study 01 and SpaceX’s orbital infrastructure dominance in Case Study 02, the SMAF Sprint now turns to the physical edge of intelligence: Embodied AI.

While Elon Musk packages “infrastructure + AI” into a grand capital narrative, China’s humanoid robotics sector is executing a dual-track playbook.

Unitree drives the market through cost disruption. Agibot drives it through strategic narrative and embodied intelligence.

Through the Scenario Maturity Assessment Framework, or SMAF, these two companies are not just robotics competitors. They represent two different answers to the same strategic question: How does a humanoid robot move from technical spectacle to commercial readiness?

Playbook A: Unitree’s “Cost Shock”

Unitree’s breakthrough is industrial, not just technical.

Leveraging China’s mature electric vehicle (EV) supply chain, they’ve driven humanoid pricing below $20,000 — shifting the market psychology from “futuristic tech demo” to “purchasable hardware.”.

In SMAF terms, this reflects world-class execution in Supply Chain Maturity and Commercial Disruption Potential. It lowers the barrier for widespread developer experimentation while forcing high-cost global competitors onto the defensive.

Unitree’s "Cost Shock" Mans International SMAF Sprint — Unitree’s “Cost Shock”

However, cheap hardware does not guarantee a valuation premium. For enterprise buyers, the real question is:

Can it work reliably inside my operation, reduce labor burden, avoid safety issues, integrate with existing systems, and produce measurable ROI?

If a robot requires a human “babysitter” to constantly reset, maintain, or supervise it, the ROI evaporates.

The real cost isn’t the hardware. It’s the operational burden.

Unitree’s next survival test: Can we make it reliable enough that customers never regret deploying it?

Playbook B: Agibot’s Narrative-Maturity Bet

Rather than competing purely on cost, Agibot is leading with an embodied AI vision: robots that learn, adapt, and improve through real-world deployment.

In SMAF terms, Agibot exhibits strong Narrative Maturity — the ability to translate complex technology into a credible, investable story about AI entering the physical world.

Agibot’s Narrative-Maturity Bet Mans International SMAF Sprint — Agibot’s Narrative-Maturity Bet

Its maturity profile looks very different from Unitree’s:

Narrative Maturity: Strong. Positioning embodied AI as a new intelligence layer for physical work is easy for investors to grasp, granting Agibot a higher valuation ceiling.
Workflow Maturity: Testing. Agibot is moving from demos to real industrial environments to expose hidden frictions. However, field training is not scenario maturity. Performing a single task creates excitement; becoming a reliable, low-friction production tool creates purchasing confidence.
Business Maturity: Expectation-Driven. Agibot’s commercial viability hinges on a Starlink-style data flywheel: deployment → task data → better intelligence → broader deployment. If successful, they are not just selling hardware — they are building a compounding intelligence system.

The SMAF Strategic Warning: The higher the narrative maturity, the greater the pressure for scenario validation. A compelling story secures capital, but it cannot permanently replace workflow proof.

The Cultural Bridge: Why These Two Paths?

These playbooks reflect two deeper instincts within China’s technology ecosystem:

Unitree represents supply-chain alchemy. Forged in China’s brutal EV price wars, Forged in the brutal NEV price wars, it turns mature industrial capacity into a global price shock. Unitree is trying to win by industrializing the body.
Agibot represents leapfrog ambition. Aligned with national priorities for AI-driven industrial upgrades, Agibot bets that software and data can compress years of mechanical refinement. They are attempting to win by accelerating the brain.

While one path begins with manufacturing maturity and the other with intelligence ambition, both eventually face the same question: Can the robot become useful inside real workflows?

The Imperative for Founders and Investors

Cost shocks open markets. Narrative maturity lifts valuation ceilings. Data loops create compounding power. But both companies must ultimately achieve Workflow Maturity — the threshold where demos become adoption, deployment earns trust, and technology justifies a valuation premium.

The Lesson for Founders:

Do not confuse technical capability with commercial readiness.
Do not confuse low cost with customer value.
Do not confuse a strong narrative with scenario maturity.
Do not confuse deployment with true adoption.

The Diligence Test for Investors:

Which company is not just building a better machine, but entering the more mature scenario?

Valuation power won’t belong to the cheapest robot or the most ambitious story. It will belong to the company that proves its robot reduces friction and generates measurable ROI.

That is the core lesson of China’s dual-track embodied AI playbook.

And it is exactly why I built the Scenario Maturity Assessment Framework (SMAF): to help founders and investors identify the gap between technical ambition and scenario maturity before the market does.

June 21, 2026June 26, 2026

SpaceX 2.2万亿估值背后：马斯克的“成熟度捆绑”阳谋，与中国硬科技的“两条生死线”

SpaceX 2.2万亿估值背后马斯克成熟度捆绑阳谋与中国硬科技生死线 Mans International

6 月 12 日，SpaceX（代码：SPCX）登陆纳斯达克，IPO 定价每股 135 美元，募资约 750 亿美元，发行估值约 1.77 万亿美元，上市后市值一度突破 2.2 万亿美元，刷新了全球 IPO 规模纪录。

朋友圈里，有人惊叹马斯克的资本手腕，有人焦虑普通投资者被收割，有人讨论这是对 OpenAI 的 “降维打击”。

但作为科技创始人、硬科技投资人，如果你只看到这些，你就错过了这场万亿盛宴背后最核心的商业逻辑。

今天，我们不谈散户情绪，不谈资本八卦。我们用 Mans International 独家的SMAF（场景成熟度评估框架），拆解一个所有硬科技创业者都必须搞懂的问题：

马斯克是如何把三个成熟度天差地别的业务，打包成一个全球资本疯抢的万亿故事？

这对正在苦苦内卷、准备下一轮融资的中国硬科技创始人来说，到底意味着什么？

SpaceX 不是一家公司，而是一个精心设计的 “成熟度捆绑包”

传统IPO的逻辑里，投资人拿的是放大镜，评估的是“一家公司”的单品业务成熟度。

但在SpaceX的局里，投资人被要求评估的，是一个庞大的生态系统：可回收火箭、星链、星舰、xAI，以及更宏大的“火星殖民”叙事。

通过 SMAF Compass™ 2.0 的视角，我们发现了一个反直觉的真相：SpaceX 根本不是一个线性发展的商业体，而是一捆“成熟度极不均衡”的业务切片。

SpaceX 成熟度捆绑包 Mans International — SpaceX 成熟度捆绑包

第一层：星链（Starlink）—— 商业成熟度锚点

业务成熟度：★★★★★

数据成熟度：★★★★★

星链是 SpaceX IPO 无可争议的商业底座。2025 年，Starlink 所在的 Connectivity 业务收入约 114 亿美元，占 SpaceX 总收入约 61%；该业务调整后 EBITDA 利润率约 63%，成为支撑 SpaceX 未来叙事的核心现金流来源。

从海事通信、企业备份到国防韧性，痛点足够痛，买家足够清晰，价值捕获路径已被验证。

没有星链的商业成熟度，SpaceX 的整体估值将极其脆弱。

星链（Starlink）—— 商业成熟度锚点 Mans International — 星链（Starlink）—— 商业成熟度锚点

更关键的是，星链创造了数据复利循环：更多用户→更丰富的网络数据→更智能的路由算法→更好的服务体验→更高的用户付费意愿→更深的数据壁垒。

这就是 SMAF 框架中 “数据成熟度” 的终极形态：技术优势通过数据闭环自我强化，最终变成竞争对手无法逾越的护城河。

第二层：星舰（Starship）—— 叙事成熟度顶峰

叙事成熟度：★★★★★

短期业务成熟度：★☆☆☆☆

星舰承载了人类最宏大的太空想象：登月、轨道数据中心、火星殖民。

它把极度复杂的技术，转化成了一张极具记忆点的“未来期权”。

星舰（Starship）—— 叙事成熟度顶峰 Mans International — 星舰（Starship）—— 叙事成熟度顶峰

但注意：叙事成熟度满分，不等于商业成熟度满分。

星舰在短期内仍然是一个”未验证的未来期权”。它负责讲故事，拉高估值天花板，但它短期内不负责产生现金流。

第三层：xAI & Grok —— 未解决的工作流成熟度缺口

工作流成熟度：★★☆☆☆

这是 SpaceX 捆绑包里最脆弱的缺口。

xAI 和 Grok 给估值注入了巨大的”AI 想象力溢价”。但对于企业和政府用户来说，模型差异化模糊、数据信任未决、深度运营集成极度困难。

xAI & Grok —— 未解决的工作流成熟度缺口 Mans International — xAI & Grok —— 未解决的工作流成熟度缺口

看懂了吗？马斯克的阳谋就是：用一个高度成熟的基建场景（星链），去主动承担一个远未成熟的AI工作流场景（xAI），用 SpaceX 的估值为 xAI 的未来定价。

东方路径的“双轨战”：宇树的“成本休克”与智元的“高叙事赌注”

当马斯克用 SpaceX 把“基建+AI”打包成一个宏大的资本叙事时，中国的硬科技创业者在具身智能（Embodied AI）赛道上，正在书写两种完全不同的“成熟度破局”打法。

打法 A：宇树科技（Unitree）的“成本休克”

依托中国成熟的新能源车供应链，宇树把人形机器人的价格打到了约1.6万美元。在SMAF 框架的“商业成熟度”和“供应链壁垒”上，这已经是世界级。

但 SMAF 给国内狂热的硬件圈提了个醒：成本优势 ≠ 估值优势。

宇树科技（Unitree）的“成本休克” Mans International — 宇树科技（Unitree）的“成本休克”

一台需要每 2 小时停机维护 20 分钟的机器人，在标准 8 小时班次里，单日有效工作时间只有 6.7 小时。其综合产量和交付稳定性，还不如一个普通的人类熟练工。对 B端客户眼里的“工作流成熟度”就是不及格的，这根本不是生产力工具，而是需要额外配备一个高薪“保姆”的昂贵玩具。

中国硬件公司已经解决了“造得便宜”的问题，下一阶段的生死战，是谁能率先解决“用得不烦”的场景成熟度问题。

打法 B：智元机器人（Agibot）的“高叙事”赌注

与宇树的“成本休克”不同，智元选择了一条更接近 SpaceX “成熟度捆绑”的路径：用“具身智能大脑”拉高叙事天花板，再反哺场景落地。在 SMAF 框架下，其成熟度画像与宇树形成鲜明反差：

叙事成熟度：★★★★★

自带顶尖技术势能，“通用具身智能”的愿景直接对标物理 AI 最前沿，叙事拉满。

工作流成熟度：★★★☆☆（迭代中）

智元直接将机器人送入汽车总装等真实产线“实训”。但 SMAF 提醒：实训期≠场景成熟。从“能干活”到“无感融入产线且绝不添乱”，仍需跨越巨大的隐性摩擦力。

商业成熟度：★★☆☆☆（预期驱动）

出货量尚处早期，但投资人押注的是其“部署-数据-智能”的数据复利飞轮，这与星链的估值逻辑如出一辙。

SMAF 战略警示：叙事天花板越高，场景验证压力越大。

智元机器人（Agibot）的“高叙事”赌注 Mans International — 智元机器人（Agibot）的“高叙事”赌注

中国机器人双雄正在书写两种截然不同的答卷：宇树从成本端倒逼场景，智元从智能端切入场景。

在这个赛道上，宇树只需向客户证明“我足够便宜，且不添乱”；而智元则必须证明“我能比工人更聪明”。

在这场战役中，谁能率先跨越“工作流成熟度”的生死线，谁就能死死锁定下一轮的估值定价权。

灵魂拷问：你的技术，正卡在哪一层？

技术突破≠场景成熟

能力休克≠估值溢价

只有被场景吸收、能产生复利价值的技术，才真正具备投资价值。

做融资 PPT 前，先抛开技术参数，用 SMAF 场景成熟度框架问自己三个灵魂问题：

问题 1：你的 “现金牛” 在哪里？

哪个已跑通的场景，在产生稳定现金流，为你的未来研发输血？

马斯克：星链 | 你：？

没有现金牛，所有叙事都是空中楼阁 —— 这是投资人第一个会问的问题。

问题 2：你的叙事是否跑在了工作流前面？

叙事 10 分、落地 2 分的估值，一碰就碎。

牛市愿意为想象力付溢价，熊市最先压缩的，往往是“有故事、没落地”的公司。

xAI 有星链托底，你有吗？

问题 3：你的成本优势，是否转化为了场景 ROI？

便宜但不可靠，强大但难集成，都不是生产力优势，而是尚未被场景吸收的技术想象。

对于进入商业化阶段的硬科技公司，投资人不再只看你卖得多便宜，而是看你能否为客户持续创造可验证的 ROI：赚多少钱、省多少钱、降低多少运营风险。

技术成熟度，只是硬科技的入场券。场景成熟度，才是创始人拉开差距、拿超额估值的核心。

SpaceX 的万亿市值，靠的不是最强的火箭，而是极致的成熟度分层：

星链：赚钱（商业锚点）
星舰：讲故事（叙事天花板）
xAI：磨未来（工作流缺口）
打包：讲一个可信的增长故事

中国创始人要学的不是马斯克的疯狂，而是这套清醒的分层管理艺术。

你的公司，现在处于哪一层？

加入 Mans International SMAF Sprint 2026

本文是 Mans International SMAF Sprint 2026 的第 2 周深度案例研究：Case Study 02｜SpaceX 与成熟度捆绑逻辑。

不要等到市场下行周期，才被迫暴露你的成熟度缺口。

你的技术可能很强，叙事可能很有吸引力，但如果场景尚未成熟，采用率、收入质量和估值支撑，最终都会在压力测试中显露裂缝。

如果你是科技创始人、深科技 VC、产业领袖，或正在面对 AI、机器人、空间基础设施、中美科技脱钩等复杂变量的跨境战略决策者——现在最重要的，不是继续讲更大的故事，而是在市场修正之前，提前识别你的关键战略缺口。

在 Mans International，我们用 SMAF Compass™ 场景成熟度框架帮助你判断：

你的技术场景是否已经准备好规模化
真正的成熟度缺口藏在哪里
如何设计自己的“成熟度捆绑包”，支撑更可信的增长叙事与估值溢价

发送私信获取《SMAF Compass™ 闭门诊断简报》。

June 16, 2026

SpaceX IPO and the Scenario Premium

In Week 1 of the Mans International SMAF Sprint 2026, I revisited Insilico Medicine to stress-test the AI-drug premium. The conclusion was clear: the premium is no longer given for technical ambition; it must be earned through measurable scenario maturity.

This week, the SMAF Compass™ 2.0 moves from AI biotech to space infrastructure, frontier AI, and physical robotics.

The case is SpaceX. Through the SMAF lens, the IPO is a scenario-premium case: where investors are being asked to price several maturity layers at once.

Starlink is the current commercial maturity anchor.
Starship is the future capacity promise.
xAI and Grok are the AI imagination layer — but also the unresolved maturity gap.

This raises a harder question: Can mature infrastructure scenarios carry less mature AI scenarios inside the same valuation premium?

That is where the Scenario Maturity Assessment Framework, or SMAF Compass™, becomes useful.

Deconstructing the SpaceX Bundle via the SMAF Lens

A traditional IPO asks investors to value a business. The SpaceX IPO asks investors to value a system: reusable launch, Starlink, Starship, xAI, and the broader Musk narrative.

Starlink is the Anchor

Business Maturity: Starlink is the undisputed commercial anchor of the IPO. It has translated deep-tech capability into high-margin, recurring global revenue. From maritime communication and enterprise backup to national defense resilience, the pain point is urgent, the buyer is clear, and the value-capture path is proven. Without Starlink’s business maturity, the broader IPO valuation would be highly fragile.
Data Maturity: Starlink creates a compounding intelligence loop. More users and traffic generate richer network data, which improves routing, reliability, and performance. Better performance increases adoption, and greater adoption deepens the data advantage.

Starship is the Capacity Promise

Narrative Maturity: Starship nails this pillar. It gives the market a canvas for its grandest space-based imagination — lunar missions, orbital data centres, and Mars colonization. It converts staggering technical complexity into a highly memorable story of future capacity optionality.

However, while its Narrative Maturity is maximum, its short-term Business Maturity remains an unproven future option.

xAI is the Unresolved Layer

Workflow Maturity: This is the core maturity gap in the bundle. xAI and Grok inject a massive “AI imagination premium” into the valuation. Yet, serious enterprise and government users still face immense workflow friction: model differentiation, data trust, and deep operational integration.

Right now, a highly mature infrastructure scenario (Starlink) is actively carrying a far less mature workflow scenario (xAI) inside the same valuation story.

The Strategic Takeaway for Founders and VCs

Capability shock is not scenario maturity.

A technology company becomes truly investable only when the surrounding scenario matures enough to absorb the innovation and convert it into durable, compounding value.

When evaluating your own tech stack or investment pipeline this quarter, step away from technical specs and ask the tough SMAF questions:

What is your business maturity anchor? What working scenario is generating the predictable revenue needed to subsidize your future bets?
Is your narrative outpacing your workflow? If your Narrative Maturity is a 10, but your Workflow Maturity is a 2, your valuation premium is dangerously fragile.

In the frontier tech era, technology maturity is merely the baseline for entry. Scenario maturity is where the premium is actually earned.

Scenario Maturity is the Premium Mans International — Scenario Maturity is the Premium

Join the Mans International SMAF Sprint 2026

This assessment is Week 2, Case Study 02 of the Mans International SMAF Sprint 2026.

If you are a tech founder, deep-tech VC, industrial leader, or cross-border strategy decision-maker navigating AI, robotics, space infrastructure, or US-China technology decoupling, do not wait for the market to expose the gap.

Your technology may be strong. Your narrative may be compelling. But if the scenario is not mature enough, adoption, revenue, and valuation will eventually break under pressure.